First Surgical Implantation of ZIP ULTRA® MIS Interspinous Device Performed in Argentina

“The ZIP ULTRA MIS fusion system is a very intuitive and easy to use system that allows me to perform a short and safe surgery while avoiding the risk of nerve impact,” said Prof. Cerneaz and Dr. Segvic. “The instrumentation is very intuitive and the implantation is fast and simple via a small incision.”

“We are very excited to now offer our ZIP MIS product portfolio in Argentina,” said Laszlo Garamszegi, Chief Technology Officer of Aurora Spine. The ZIP family of products is designed to be simple, safe and secure and we are convinced it will improve patient outcomes in Argentina.”

“Aurora is changing spine surgery,” said Trent Northcutt, President and CEO of Aurora Spine. “The combination of the proven ONE-STEP™ locking mechanism and our minimally invasive design allows patients in Latin America to receive the Screwless Procedure™ as an alternative to pedicle screws.”

Aurora Spine’s ZIP ULTRA MIS interspinous fixation implant for spinal fusion consists of a ONE-STEP™ locking mechanism, which eliminates the use of a set screw, articulating spikes and comes in various sizes to accommodate variations in patient anatomy.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company’s commitment to – Simplifying the Complex.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information” in Aurora Spine’s final prospectus (collectively, “forward-looking information”). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine’s securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

CONTACT INFORMATION

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Sarina Mason
Chief Financial Officer
(760) 424-2004

www.aurora-spine.com